Literature DB >> 23205029

Antimicrobial resistance surveillance systems: Are potential biases taken into account?

Olivia Rempel1, Johann Dd Pitout, Kevin B Laupland.   

Abstract

BACKGROUND: The validity of surveillance systems has rarely been a topic of investigation.
OBJECTIVE: To assess potential biases that may influence the validity of contemporary antimicrobial-resistant (AMR) pathogen surveillance systems.
METHODS: In 2008, reports of laboratory-based AMR surveillance systems were identified by searching Medline. Surveillance systems were appraised for six different types of bias. Scores were assigned as '2' (good), '1' (fair) and '0' (poor) for each bias.
RESULTS: A total of 22 surveillance systems were included. All studies used appropriate denominator data and case definitions (score of 2). Most (n=18) studies adequately protected against case ascertainment bias (score = 2), with three studies and one study scoring 1 and 0, respectively. Only four studies were deemed to be free of significant sampling bias (score = 2), with 17 studies classified as fair, and one as poor. Eight studies had explicitly removed duplicates (score = 2). Seven studies removed duplicates, but lacked adequate definitions (score = 1). Seven studies did not report duplicate removal (score = 0). Eighteen of the studies were considered to have good laboratory methodology, three had some concerns (score = 1), and one was considered to be poor (score = 0).
CONCLUSION: Contemporary AMR surveillance systems commonly have methodological limitations with respect to sampling and multiple counting and, to a lesser degree, case ascertainment and laboratory practices. The potential for bias should be considered in the interpretation of surveillance data.

Keywords:  Antimicrobial resistance; Bias; Epidemiology; Incidence; Risk

Year:  2011        PMID: 23205029      PMCID: PMC3222764          DOI: 10.1155/2011/276017

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  47 in total

1.  The current status of surveillance of resistance to antimicrobial agents: report on a meeting.

Authors:  Pamela A Hunter; David S Reeves
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

2.  Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.

Authors:  J W Tapsall; E A Limnios; Denise Murphy
Journal:  J Antimicrob Chemother       Date:  2007-11-06       Impact factor: 5.790

3.  Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover.

Authors:  Rosy Reynolds; Paul C Lambert; Paul R Burton
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

Review 4.  Public health surveillance in the United States.

Authors:  S B Thacker; R L Berkelman
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

5.  Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance.

Authors:  Kevin B Laupland; Terry Ross; Johann D D Pitout; Deirdre L Church; Daniel B Gregson
Journal:  Clin Invest Med       Date:  2007       Impact factor: 0.825

6.  Active bacterial core surveillance of the emerging infections program network.

Authors:  A Schuchat; T Hilger; E Zell; M M Farley; A Reingold; L Harrison; L Lefkowitz; R Danila; K Stefonek; N Barrett; D Morse; R Pinner
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

7.  Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance.

Authors:  D Kumar; A Humar; A Plevneshi; D Siegal; N Franke; K Green; A McGeer
Journal:  Bone Marrow Transplant       Date:  2008-01-07       Impact factor: 5.483

8.  Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).

Authors:  Matsuhisa Inoue; David J Farrell; Kenichi Kaneko; Kouji Akizawa; Shinichi Fujita; Mitsuo Kaku; Jun Igari; Keizo Yamaguchi; Kiyoharu Yamanaka; Mitsuharu Murase; Seishi Asari; Yoichi Hirakata; Hisashi Baba; Hideyuki Itaha
Journal:  Microb Drug Resist       Date:  2008-06       Impact factor: 3.431

9.  Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.

Authors:  Marianna Ofner-Agostini; B Lynn Johnston; Andrew E Simor; John Embil; Anne Matlow; Michael Mulvey; Debbie Ormiston; John Conly
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

10.  Invasive pneumococcal disease in New Zealand 1998-2005: capsular serotypes and antimicrobial resistance.

Authors:  H M Heffernan; D R Martin; R E Woodhouse; J Morgan; T K Blackmore
Journal:  Epidemiol Infect       Date:  2007-05-17       Impact factor: 2.451

View more
  7 in total

Review 1.  Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings.

Authors:  Elizabeth A Ashley; Nandini Shetty; Jean Patel; Rogier van Doorn; Direk Limmathurotsakul; Nicholas A Feasey; Iruka N Okeke; Sharon J Peacock
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

2.  High Burden of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Bacteremia in Older Adults: A Seven-Year Study in Two Rural Thai Provinces.

Authors:  Pongpun Sawatwong; Patranuch Sapchookul; Toni Whistler; Christopher J Gregory; Ornuma Sangwichian; Sirirat Makprasert; Possawat Jorakate; Prasong Srisaengchai; Somsak Thamthitiwat; Chidchanok Promkong; Pongnapat Nanvatthanachod; Muthita Vanaporn; Julia Rhodes
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

Review 3.  Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.

Authors:  Pascale Salameh; Christine Roques; Katia Iskandar; Laurent Molinier; Souheil Hallit; Massimo Sartelli; Timothy Craig Hardcastle; Mainul Haque; Halyna Lugova; Sameer Dhingra; Paras Sharma; Salequl Islam; Irfan Mohammed; Isa Naina Mohamed; Pierre Abi Hanna; Said El Hajj; Nurul Adilla Hayat Jamaluddin
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-31       Impact factor: 4.887

4.  Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada.

Authors:  K B Laupland; K Pasquill; E C Parfitt; P Naidu; L Steele
Journal:  Epidemiol Infect       Date:  2016-03-21       Impact factor: 4.434

5.  Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana.

Authors:  Japheth A Opintan; Mercy J Newman; Reuben E Arhin; Eric S Donkor; Martha Gyansa-Lutterodt; William Mills-Pappoe
Journal:  Infect Drug Resist       Date:  2015-11-18       Impact factor: 4.003

6.  Laboratory-based versus population-based surveillance of antimicrobial resistance to inform empirical treatment for suspected urinary tract infection in Indonesia.

Authors:  Adhi Kristianto Sugianli; Franciscus Ginting; R Lia Kusumawati; Ida Parwati; Menno D de Jong; Frank van Leth; Constance Schultsz
Journal:  PLoS One       Date:  2020-03-30       Impact factor: 3.240

Review 7.  Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review.

Authors:  Adhi Kristianto Sugianli; Franciscus Ginting; Ida Parwati; Menno D de Jong; Frank van Leth; Constance Schultsz
Journal:  JAC Antimicrob Resist       Date:  2021-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.